These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22034971)

  • 1. The endocannabinoid system misfires in ADHD mice (commentary on Castelli et al.).
    Bracci E
    Eur J Neurosci; 2011 Nov; 34(9):1368. PubMed ID: 22034971
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter.
    Castelli M; Federici M; Rossi S; De Chiara V; Napolitano F; Studer V; Motta C; Sacchetti L; Romano R; Musella A; Bernardi G; Siracusano A; Gu HH; Mercuri NB; Usiello A; Centonze D
    Eur J Neurosci; 2011 Nov; 34(9):1369-77. PubMed ID: 22034972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoids activate transient receptor potential vanilloid 1 receptors to reduce hyperdopaminergia-related hyperactivity: therapeutic implications.
    Tzavara ET; Li DL; Moutsimilli L; Bisogno T; Di Marzo V; Phebus LA; Nomikos GG; Giros B
    Biol Psychiatry; 2006 Mar; 59(6):508-15. PubMed ID: 16199010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
    Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
    Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine.
    Aarts E; van Holstein M; Hoogman M; Onnink M; Kan C; Franke B; Buitelaar J; Cools R
    Behav Pharmacol; 2015 Feb; 26(1-2):227-40. PubMed ID: 25485641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine transporter haplotype and reward-related striatal responses in adult ADHD.
    Hoogman M; Onnink M; Cools R; Aarts E; Kan C; Arias Vasquez A; Buitelaar J; Franke B
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):469-78. PubMed ID: 22749356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease.
    Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M
    Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
    Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
    Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids/glucocorticoid receptors effect on dopaminergic neurotransmitters in ADHD rats.
    Chen Y; Zheng X; Xie L; Huang L; Ke Z; Zheng J; Lu H; Hu J
    Brain Res Bull; 2017 May; 131():214-220. PubMed ID: 28458039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine regulates frontocorticostriatal dopamine transporter density and improves attention and cognitive deficits in an animal model of attention deficit hyperactivity disorder.
    Pandolfo P; Machado NJ; Köfalvi A; Takahashi RN; Cunha RA
    Eur Neuropsychopharmacol; 2013 Apr; 23(4):317-28. PubMed ID: 22561003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder.
    Shaw P; Gornick M; Lerch J; Addington A; Seal J; Greenstein D; Sharp W; Evans A; Giedd JN; Castellanos FX; Rapoport JL
    Arch Gen Psychiatry; 2007 Aug; 64(8):921-31. PubMed ID: 17679637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder.
    Richardson JR; Taylor MM; Shalat SL; Guillot TS; Caudle WM; Hossain MM; Mathews TA; Jones SR; Cory-Slechta DA; Miller GW
    FASEB J; 2015 May; 29(5):1960-72. PubMed ID: 25630971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of adult attention-deficit/hyperactivity disorder.
    Faraone SV
    Psychiatr Clin North Am; 2004 Jun; 27(2):303-21. PubMed ID: 15063999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine risk and paternal ADHD symptomatology associated with ADHD symptoms in four and a half-year-old boys.
    Auerbach JG; Atzaba-Poria N; Berger A; Landau R; Arbelle S; Raz Y; Ebstein R
    Psychiatr Genet; 2010 Aug; 20(4):160-5. PubMed ID: 20421851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine drinking potentiates cannabinoid transmission in the striatum: interaction with stress effects.
    Rossi S; De Chiara V; Musella A; Mataluni G; Sacchetti L; Siracusano A; Bernardi G; Usiello A; Centonze D
    Neuropharmacology; 2009 Mar; 56(3):590-7. PubMed ID: 19027757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impulsivity is related to striatal dopamine transporter availability in healthy males.
    Costa A; la Fougère C; Pogarell O; Möller HJ; Riedel M; Ettinger U
    Psychiatry Res; 2013 Mar; 211(3):251-6. PubMed ID: 23158972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder.
    van Dyck CH; Quinlan DM; Cretella LM; Staley JK; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Am J Psychiatry; 2002 Feb; 159(2):309-12. PubMed ID: 11823278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.